Noticias

ADCIS attended at the National Congress of the Francophone Diabetes Society held at Parc Chanot in Marseille from 26th to […]

The new version of the EyePrint Designer (EPD) Software has been presented at the GSLS 2019 Symposium.

Introduced at CES’2019, the innovation named OphtAI is an artificial intelligence resulting from three years of collaborative research between researchers, clinicians, and manufacturers.

At Ophthalmology 2018 in Moscow, Russia, Bruno Laÿ, ADCIS CEO, presented a joint work with Fondation Rothschild, the “3D Image processing and image display of the vascular network in OCT-Angiography Images”.

Bruno Laÿ, ADCIS CEO, made a presentation relying on his expertise and his excellence in various fields as Image Processing, Analysis, and Understanding in Naples, Italy.

Two innovative research projects were presented at the 124th International Congress of the French Society of Ophthalmology (SFO), which was held in Paris from May 5 to 8, 2018.

From April 29 to May 3, 2018, ADCIS attented the Annual Convention of the Association for Research in Vision and Ophthalmology (ARVO) in Honolulu, Hawaii, USA.

1st Ceos Project campaign: a technical success across the board…

Effective on 3/31/2017, Amerinex Applied Imaging, Inc., ended its thirty-one year history of developing, selling, and servicing imaging-based software products, and transferred its activities and rights to Adcis, Inc.